Delivery Order SPE2DB20D2002-SPE2DB23FL69B
Award Date
9/12/23
Potential Completion Date
9/13/23
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $1,509.01, is for the delivery of LINZESS 290 MCG CAPSULES to support medical requirements. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant IDC with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of LINZESS 72 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $2,674.11 and a completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $1,152.75, is for the delivery of LINZESS 145 MCG CAPSULE pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FR67C) valued at $1,603.54 for LINZESS 290 MCG CAPSULE medical supplies. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 28, 2022, with a completion date of January 31, 2022. The contract is not associated with a set-aside program and was awarded under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $1,127.46 and covers the delivery of LINZESS 145 MCG CAPSULE UU 30S, a medication for the treatment of gastrointestinal conditions. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,528.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,311.19 firm fixed-price delivery order is for LINZESS 145 MCG capsules and has an ultimate completion date of April 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,411.52 firm-fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $16,433.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the supply of LINZESS 72 MCG CAPSULE pharmaceutical products. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts to provide a wide range of prescription medications, medical supplies, and critical care materials to support military...